← Product Code [MMK](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/MMK) · K021983 # ULTI GUARD HOME INSULIN SYRINGE CONTAINER (K021983) _Ultimed, Inc. · MMK · Sep 16, 2002 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/MMK/K021983 ## Device Facts - **Applicant:** Ultimed, Inc. - **Product Code:** [MMK](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/MMK.md) - **Decision Date:** Sep 16, 2002 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5570 - **Device Class:** Class 2 - **Review Panel:** General Hospital ## Indications for Use The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container by Ulti Med Inc. is intended to be used to transport, store and dispose of insulin syringes in the home. After use the syringes are to be deposited into the container for safe storage and eventual disposal according to local regulations. ## Device Story Device consists of a combined dispenser and sharps container pre-loaded with 100 insulin syringes. User removes new syringes from dispenser as needed; after injection, user deposits used syringes into integrated sharps container. Device facilitates safe storage and disposal of sharps in home environment. Primary benefit is convenience and safety for home-based insulin administration. ## Clinical Evidence Bench testing only. Testing included impact resistance, puncture resistance, leak resistance, sharps access, and stability. ## Technological Characteristics Integrated plastic dispenser and sharps container. Single-use. No electronic components or software. ## Regulatory Identification A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set. ## Predicate Devices - Becton Dickinson Home Sharps Container ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## SEP 1 6 2002 510(k) Number: K021983 UltiGuard Home Insulin Syringe Dispenser and Sharps Container ## 510(k) Summary of Safety and Effectiveness - 1) The submitter of this submission is: Ulti Med Inc. 287 E. Sixth Street St. Paul, MN 55101 Telephone (651) 291-7909 Fax (651) 291-7074 The contact person is: Charles W. Erickson e-mail: c.erickson@ulti-care.com On this 10th day of September, 2002. - 2) The trade name of the package shall be "Ulti Guard Home Insulin Syringe Dispenser and Sharps Container". - The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container has the 3) comparable intended use as the pre marketed Becton Dickinson Home Sharps Container. - 4) The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container has been tested with acceptable results for Impact Resistance, Puncture Resistance, Leak Resistance Sharps Access and Stability. - Ulti Guard Home syringe contains 100 UltiCare insulin syringes. Syringes can 5) be selectively removed as needed, and used syringes conveniently deposited back into the top of the container for safe storage. Ulti Guard syringes and container are single use only. - The intended use is for the storage and disposal of insulin syringes. 6) - The UltiGuard Home syringe container differs from the predicate device as the disposal 7) container is sold with the syringes. As syringes are removed and used, the container has the purpose of safely storing the used syringes. This promotes the convenient and safe disposal of used syringes in the home. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a representation of human figures. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## SEP 1 6 2002 Mr. Charles Erickson President Ulti Med, Incorporated 287 East Sixth Street Saint Paul, Minnesota 55101 Re: K021983 Trade/Device Name: Ulti Guard Home Insulin Syringe Dispenser and Sharps Container Regulation Number: 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: MMK Dated: August 28, 2002 Received: August 29, 2002 Dear Mr. Erickson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. {2}------------------------------------------------ Page 2 - Mr. Erickson You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.qov/cdrh/dsma/dsmamain.html Sincerely yours, Suain Ranes ヶ Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ 510(k) Number: K021983 UltiGuard Home Insulin Syringe Dispenser and Sharps Container ## Indication of Use Statement The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container by Ulti Med Inc. is a The Ulti Guard Home Insultif Syrings Disponse insulins viringes in the home. After use the intended to be used to transport, store and disponse thanks of to be and eventual disposal according to local regulations. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use X (Pcr 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Riu li tai lin (Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices 510(k) Number. KC 3 19 8 3 --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/MMK/K021983](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/MMK/K021983) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com